By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company 180 Life Sciences Corp.

180 Life Sciences Corp. (ATNFW)

NASDAQ Currency in USD
$0.43
-$0.03
-6.52%
Last Update: 15 Aug 2025, 20:00
$1.23B
Market Cap
-0.24
P/E Ratio (TTM)
Forward Dividend Yield
$0.36 - $0.44
52 Week Range

ATNFW Stock Price Chart

Explore 180 Life Sciences Corp. interactive price chart. Choose custom timeframes to analyze ATNFW price movements and trends.

ATNFW Company Profile

Discover essential business fundamentals and corporate details for 180 Life Sciences Corp. (ATNFW) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

27 Jun 2017

Employees

4.00

CEO

Lloyd Blair Jordan

Description

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.

ATNFW Financial Timeline

Browse a chronological timeline of 180 Life Sciences Corp. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 23 Jul 2025

EPS came in at -$0.30 .

Earnings released on 15 May 2025

EPS came in at -$2.59 .

Earnings released on 31 Mar 2025

EPS came in at -$4.67 , while revenue for the quarter reached $95.11K .

Earnings released on 14 Nov 2024

EPS came in at -$0.85 .

Earnings released on 12 Aug 2024

EPS came in at $0.01 .

Earnings released on 15 May 2024

EPS came in at -$1.68 .

Earnings released on 23 Mar 2024

EPS came in at -$2.29 surpassing the estimated -$22.80 by +89.94%, while revenue for the quarter reached $166.03K .

Earnings released on 9 Nov 2023

EPS came in at -$24.53 surpassing the estimated -$26.60 by +7.79%.

Earnings released on 15 Aug 2023

EPS came in at -$13.37 surpassing the estimated -$26.60 by +49.75%.

Earnings released on 15 May 2023

EPS came in at -$24.15 surpassing the estimated -$38.00 by +36.46%.

Earnings released on 31 Mar 2023

EPS came in at -$1.10 surpassing the estimated -$41.80 by +97.36%.

Earnings released on 10 Nov 2022

EPS came in at -$0.55 surpassing the estimated -$38.00 by +98.56%.

Earnings released on 9 Aug 2022

EPS came in at $0.09 .

Earnings released on 16 May 2022

EPS came in at $0.05 .

Earnings released on 31 Mar 2022

EPS came in at $0.12 .

Earnings released on 12 Nov 2021

EPS came in at $0.54 .

Earnings released on 16 Aug 2021

EPS came in at -$0.75 .

Earnings released on 17 Jul 2021

EPS came in at -$0.58 .

Earnings released on 9 Jul 2021

EPS came in at -$0.57 .

Earnings released on 24 Nov 2020

EPS came in at -$1.49 .

ATNFW Stock Performance

Access detailed ATNFW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run